NASDAQ:PRVA - Privia Health Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $41.83
  • Forecasted Upside: -9.55 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$46.25
▲ +0.9 (1.98%)

This chart shows the closing price for PRVA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Privia Health Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRVA

Analyst Price Target is $41.83
▼ -9.55% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Privia Health Group in the last 3 months. The average price target is $41.83, with a high forecast of $47.00 and a low forecast of $40.00. The average price target represents a -9.55% upside from the last price of $46.25.

This chart shows the closing price for PRVA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Privia Health Group.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2021Truist SecuritiesInitiated CoverageBuy$40.00High
5/24/2021Piper SandlerInitiated CoverageOverweight$40.00High
5/24/2021JPMorgan Chase & Co.Initiated CoverageOverweight$40.00High
5/24/2021TruistInitiated CoverageBuy$40.00High
5/24/2021Canaccord GenuityInitiated CoverageBuy$47.00High
5/24/2021William BlairInitiated CoverageOutperformHigh
5/24/2021Credit Suisse GroupInitiated CoverageOutperform$44.00High
(Data available from 6/22/2016 forward)
Privia Health Group logo
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Read More

Today's Range

Now: $46.25
Low: $44.00
High: $46.79

50 Day Range

MA: N/A

52 Week Range

Now: $46.25
Low: $27.15
High: $46.79

Volume

1,552,705 shs

Average Volume

747,022 shs

Market Capitalization

$4.89 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Privia Health Group?

The following sell-side analysts have issued research reports on Privia Health Group in the last twelve months: Canaccord Genuity, Credit Suisse Group AG, JPMorgan Chase & Co., Piper Sandler, Truist, Truist Securities, and William Blair.
View the latest analyst ratings for PRVA.

What is the current price target for Privia Health Group?

6 Wall Street analysts have set twelve-month price targets for Privia Health Group in the last year. Their average twelve-month price target is $41.83, suggesting a possible downside of 9.5%. Canaccord Genuity has the highest price target set, predicting PRVA will reach $47.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $40.00 for Privia Health Group in the next year.
View the latest price targets for PRVA.

What is the current consensus analyst rating for Privia Health Group?

Privia Health Group currently has 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRVA will outperform the market and that investors should add to their positions of Privia Health Group.
View the latest ratings for PRVA.

What other companies compete with Privia Health Group?

How do I contact Privia Health Group's investor relations team?

The company's listed phone number is 571 366 8850 and its investor relations email address is [email protected] The official website for Privia Health Group is www.priviahealth.com.